Document is current
Any future updates will be listed below
-
Authors
Eris, Cansu
Zu, Cheng https://orcid.org/0000-0003-3471-4338
Xiao, Yanling https://orcid.org/0000-0003-1755-1709
Platten, Michael https://orcid.org/0000-0002-4746-887X
Sun, Chong https://orcid.org/0000-0001-9008-2158
- License Information
-
More Information
Article History
Accepted: 15 April 2026
First Online: 18 May 2026
Competing interests
: M.P. is an inventor on patents related to IDH1(R132H) peptide vaccines and is the founder of T celltech GmbH. M.P. has received research support from Servier, Pfizer, Merck, Bayer and Roche, and consulting honoraria from Servier and Cellestia (all outside of this work). C.S. is an inventor on patent applications covering the therapeutic and diagnostic use of P2RY2 as a target. All other authors declare no competing interests.
